Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
34
pubmed:dateCreated
2007-11-30
pubmed:abstractText
The objective of this study was to evaluate the impact of positron emission tomography (PET) using fluorine-18-fluorodeoxyglucose (FDG) for initial staging and therapy planning in pediatric sarcoma patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5435-41
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18048826-Adolescent, pubmed-meshheading:18048826-Bone Neoplasms, pubmed-meshheading:18048826-Child, pubmed-meshheading:18048826-Child, Preschool, pubmed-meshheading:18048826-Female, pubmed-meshheading:18048826-Fluorodeoxyglucose F18, pubmed-meshheading:18048826-Humans, pubmed-meshheading:18048826-Infant, pubmed-meshheading:18048826-Lung Neoplasms, pubmed-meshheading:18048826-Lymph Nodes, pubmed-meshheading:18048826-Lymphatic Metastasis, pubmed-meshheading:18048826-Male, pubmed-meshheading:18048826-Neoplasm Staging, pubmed-meshheading:18048826-Osteosarcoma, pubmed-meshheading:18048826-Positron-Emission Tomography, pubmed-meshheading:18048826-Prospective Studies, pubmed-meshheading:18048826-Radiopharmaceuticals, pubmed-meshheading:18048826-Rhabdomyosarcoma, pubmed-meshheading:18048826-Sarcoma, pubmed-meshheading:18048826-Sarcoma, Ewing, pubmed-meshheading:18048826-Tomography, X-Ray Computed
pubmed:year
2007
pubmed:articleTitle
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
pubmed:affiliation
Klinik für Pädiatrie m.S. Onkologie und Hämatologie, Charité-Universitätsmedizin Berlin, Berlin.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study